BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18245528)

  • 41. CD94 1A transcripts characterize lymphoblastic lymphoma/leukemia of immature natural killer cell origin with distinct clinical features.
    Lin CW; Liu TY; Chen SU; Wang KT; Medeiros LJ; Hsu SM
    Blood; 2005 Nov; 106(10):3567-74. PubMed ID: 16046525
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IgH and TCRgamma gene rearrangements, cyclin A1 and HOXA9 gene expression in biphenotypic acute leukemias.
    Golemović M; Sucić M; Zadro R; Mrsić S; Mikulić M; Labar B; Rajić LJ; Batinić D
    Leuk Res; 2006 Feb; 30(2):211-21. PubMed ID: 16102826
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [HOX11L2 expression and its clinical significance in paraffin-embedded T-lymphoblastic lymphoma].
    Pan Y; Li GD; Liu WP; Zhou Q; Zhang WY
    Zhonghua Xue Ye Xue Za Zhi; 2005 Oct; 26(10):585-8. PubMed ID: 16532965
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The application of conventional cytogenetics, FISH, and RT-PCR to detect genetic changes in 70 children with ALL.
    Soszynska K; Mucha B; Debski R; Skonieczka K; Duszenko E; Koltan A; Wysocki M; Haus O
    Ann Hematol; 2008 Dec; 87(12):991-1002. PubMed ID: 18633615
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TLX1/HOX11 transcription factor inhibits differentiation and promotes a non-haemopoietic phenotype in murine bone marrow cells.
    Dixon DN; Izon DJ; Dagger S; Callow MJ; Taplin RH; Kees UR; Greene WK
    Br J Haematol; 2007 Jul; 138(1):54-67. PubMed ID: 17555447
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic and oncogenic relevance of TLX1/HOX11 expression level in T-ALLs.
    Bergeron J; Clappier E; Radford I; Buzyn A; Millien C; Soler G; Ballerini P; Thomas X; Soulier J; Dombret H; Macintyre EA; Asnafi V
    Blood; 2007 Oct; 110(7):2324-30. PubMed ID: 17609427
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Tandem application of flow cytometry and polymerase chain reaction for choice targets of minimal residual disease in childhood acute lymphoblastic leukemia].
    Tie LJ; Gu LJ; Jiang LM; Zhao JC; Chen J; Pan C; Dong L; Chen J; Xue HL; Tang JY; Wang YP
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Apr; 11(4):246-50. PubMed ID: 19374803
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Peripheral T-cell lymphoma with follicular T-cell markers.
    Rodríguez-Pinilla SM; Atienza L; Murillo C; Pérez-Rodríguez A; Montes-Moreno S; Roncador G; Pérez-Seoane C; Domínguez P; Camacho FI; Piris MA
    Am J Surg Pathol; 2008 Dec; 32(12):1787-99. PubMed ID: 18779728
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transformation of follicular lymphoma to precursor B-cell lymphoblastic lymphoma with c-myc gene rearrangement as a critical event.
    Young KH; Xie Q; Zhou G; Eickhoff JC; Sanger WG; Aoun P; Chan WC
    Am J Clin Pathol; 2008 Jan; 129(1):157-66. PubMed ID: 18089500
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primary T-cell lymphoma of the retina and cerebellum: immunophenotypic and gene rearrangement confirmation.
    Bhat PV; Jakobiec FA; Papaliodis G; Sobrin L
    Am J Ophthalmol; 2009 Sep; 148(3):350-60. PubMed ID: 19477711
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies.
    Pai RK; Mullins FM; Kim YH; Kong CS
    Cancer; 2008 Oct; 114(5):323-32. PubMed ID: 18798522
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thymic adult T-cell acute lymphoblastic leukemia stratified in standard- and high-risk group by aberrant HOX11L2 expression: experience of the German multicenter ALL study group.
    Baak U; Gökbuget N; Orawa H; Schwartz S; Hoelzer D; Thiel E; Burmeister T;
    Leukemia; 2008 Jun; 22(6):1154-60. PubMed ID: 18368072
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human immunodeficiency virus-associated precursor T-lymphoblastic leukemia/lymphoblastic lymphoma: report of a case and review of the literature.
    Lorenzon D; Perin T; Bulian P; De Re V; Caggiari L; Michieli M; Manuele R; Spina M; Gattei V; Fasan M; Tirelli U; Canzonieri V
    Hum Pathol; 2009 Jul; 40(7):1045-9. PubMed ID: 19427018
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chromosome abnormalities in advanced stage T-cell lymphoblastic lymphoma of children and adolescents: a report from Japanese Paediatric Leukaemia/Lymphoma Study Group (JPLSG) and review of the literature.
    Sekimizu M; Sunami S; Nakazawa A; Hayashi Y; Okimoto Y; Saito AM; Horibe K; Tsurusawa M; Mori T
    Br J Haematol; 2011 Sep; 154(5):612-7. PubMed ID: 21689091
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monitoring minimal residual disease with flow cytometry, antigen-receptor gene rearrangements and fusion transcript quantification in Philadelphia-positive childhood acute lymphoblastic leukemia.
    Thörn I; Botling J; Hermansson M; Lönnerholm G; Sundström C; Rosenquist R; Barbany G
    Leuk Res; 2009 Aug; 33(8):1047-54. PubMed ID: 19157547
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia.
    Ferrando AA; Neuberg DS; Dodge RK; Paietta E; Larson RA; Wiernik PH; Rowe JM; Caligiuri MA; Bloomfield CD; Look AT
    Lancet; 2004 Feb; 363(9408):535-6. PubMed ID: 14975618
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRgammadelta lineage.
    Asnafi V; Radford-Weiss I; Dastugue N; Bayle C; Leboeuf D; Charrin C; Garand R; Lafage-Pochitaloff M; Delabesse E; Buzyn A; Troussard X; Macintyre E
    Blood; 2003 Aug; 102(3):1000-6. PubMed ID: 12676784
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monoclonality and oligoclonality of T cell receptor beta gene in angioimmunoblastic T cell lymphoma.
    Shah ZH; Harris S; Smith JL; Hodges E
    J Clin Pathol; 2009 Feb; 62(2):177-81. PubMed ID: 18952689
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TLX1-induced T-cell acute lymphoblastic leukemia.
    De Keersmaecker K; Ferrando AA
    Clin Cancer Res; 2011 Oct; 17(20):6381-6. PubMed ID: 21705452
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
    De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J
    Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.